Empowerment program to reduce unnecessary UTI treatment in spinal cord injury
Part of Brain & nervous system, Injuries & trauma, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a program designed to help Veterans with spinal cord injury and bladder issues avoid unnecessary antibiotics for UTIs. It aims to empower you to manage your condition and reduce overtreatment of bacteria in your urine that aren't causing symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Veteran with a spinal cord injury or disease and a related bladder condition (neurogenic bladder).
- You have been treated for at least one urinary tract infection (UTI) in the past year.
- You have access to a telephone.
- You get your primary care at the Michael E. DeBakey VA Medical Center in Houston, Texas.
- You did not help create or test this program during its development.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a nerve-stimulation approach to improve bladder control in people with spinal cord injury. It specifically targets bladder problems that require clean intermittent catheter use and includes regular testing over 6 months.
This study tests a program to help people with spinal cord injury manage chronic pain. You will learn coping skills through online sessions and activities you can do at home.
This study tests whether pelvic floor muscle exercises can improve bladder, bowel, and sexual function in people with a spinal cord injury. If you have ongoing symptoms in these areas and a stable health routine, this trial may help you learn ways to strengthen those muscles.
This trial tests whether using mild electrical pulses on the spinal cord can help people with spinal cord injuries regain better control of their bladder. It might be an option if you've tried other treatments without success.
This early-stage trial tests a new treatment combining an antibiotic (gentamicin) and beneficial bacteria (lactobacillus) instilled directly into the bladder to help prevent urinary tract infections in people with neurogenic bladder—a condition where nerve damage affects bladder control. The goal is to see if this approach is safe and helps reduce infection risk.
This trial tests whether a medication called OM-89 (a bacterial extract taken by mouth) can help reduce how often you need antibiotics for urinary tract infections (UTIs). It is for people with a neurogenic bladder from a spinal cord injury who use a catheter to empty their bladder and have had many UTIs in the past year.
Hear when a new Spinal Cord Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.